227 related articles for article (PubMed ID: 24442762)
21. A review of clinical safety data for sumatriptan nasal powder administered by a breath powered exhalation delivery system in the acute treatment of migraine.
Silberstein SD
Expert Opin Drug Saf; 2018 Jan; 17(1):89-97. PubMed ID: 28994319
[TBL] [Abstract][Full Text] [Related]
22. A sumatriptan patch (Zecuity) for migraine.
Med Lett Drugs Ther; 2015 Nov; 57(1481):151-2. PubMed ID: 26529132
[No Abstract] [Full Text] [Related]
23. Onzetra Xsail--sumatriptan nasal powder.
Med Lett Drugs Ther; 2016 Jul; 58(1499):92-3. PubMed ID: 27403783
[No Abstract] [Full Text] [Related]
24. Pneumatosis intestinalis post steroid use in a patient with immune-related adverse events: Case report, literature review and FAERS analysis.
Zhang T; Cao M; Zhao B; Pan C; Lin L; Tang C; Zhao Z; Duan J; Wang L; Liang J
Front Pharmacol; 2023; 14():1133551. PubMed ID: 36998618
[No Abstract] [Full Text] [Related]
25. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM
Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
[TBL] [Abstract][Full Text] [Related]
26. The risk of ischaemic colitis in irritable bowel syndrome patients treated with serotonergic therapies.
Lewis JH
Drug Saf; 2011 Jul; 34(7):545-65. PubMed ID: 21663331
[TBL] [Abstract][Full Text] [Related]
27. The Weber effect and the United States Food and Drug Administration's Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010.
Hoffman KB; Dimbil M; Erdman CB; Tatonetti NP; Overstreet BM
Drug Saf; 2014 Apr; 37(4):283-94. PubMed ID: 24643967
[TBL] [Abstract][Full Text] [Related]
28. Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS).
Yu RJ; Krantz MS; Phillips EJ; Stone CA
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):819-829.e2. PubMed ID: 32992044
[TBL] [Abstract][Full Text] [Related]
29. Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.
Law S; Derry S; Moore RA
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD008541. PubMed ID: 27096438
[TBL] [Abstract][Full Text] [Related]
30. Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine.
Tfelt-Hansen P; Hougaard A
Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):91-103. PubMed ID: 23228070
[TBL] [Abstract][Full Text] [Related]
31. Enoxaparin-Induced Liver Injury: Case Report and Review of the Literature and FDA Adverse Event Reporting System (FAERS).
Hahn KJ; Morales SJ; Lewis JH
Drug Saf Case Rep; 2015 Dec; 2(1):17. PubMed ID: 27747729
[TBL] [Abstract][Full Text] [Related]
32. Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Subeesh V; Maheswari E; Singh H; Beulah TE; Swaroop AM
Curr Drug Saf; 2019; 14(1):21-26. PubMed ID: 30362421
[TBL] [Abstract][Full Text] [Related]
33. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
Natarajan S; Jabbour JT; Webster CJ; Richardson MS
Headache; 2004; 44(10):969-77. PubMed ID: 15546259
[TBL] [Abstract][Full Text] [Related]
34. Reporting adverse drug reactions.
Wooten J
South Med J; 2009 Apr; 102(4):345-6. PubMed ID: 19279544
[No Abstract] [Full Text] [Related]
35. Sumatriptan: a potent drug for management of corneal lesion pain.
Gamulescu MA; May A; Lohmann CP; Gabel VP
J Cataract Refract Surg; 2005 Jun; 31(6):1255-6. PubMed ID: 16039510
[No Abstract] [Full Text] [Related]
36. Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.
Zhou Z; Hultgren KE
JMIR Public Health Surveill; 2020 Sep; 6(3):e19266. PubMed ID: 32996889
[TBL] [Abstract][Full Text] [Related]
37. Automatic signal extraction, prioritizing and filtering approaches in detecting post-marketing cardiovascular events associated with targeted cancer drugs from the FDA Adverse Event Reporting System (FAERS).
Xu R; Wang Q
J Biomed Inform; 2014 Feb; 47():171-7. PubMed ID: 24177320
[TBL] [Abstract][Full Text] [Related]
38. Ischemic colitis after enema administration: Incidence, timing, and clinical features.
Ahn Y; Hong GS; Lee JH; Lee CW; Kim SO
World J Gastroenterol; 2020 Nov; 26(41):6442-6454. PubMed ID: 33244204
[TBL] [Abstract][Full Text] [Related]
39. Sumatriptan plus naproxen for acute migraine attacks in adults.
Law S; Derry S; Moore RA
Cochrane Database Syst Rev; 2013 Oct; (10):CD008541. PubMed ID: 24142431
[TBL] [Abstract][Full Text] [Related]
40. Sumatriptan therapy for headache and acute myocardial infarction.
Barra S; Lanero S; Madrid A; Materazzi C; Vitagliano G; Ames PR; Gaeta G
Expert Opin Pharmacother; 2010 Nov; 11(16):2727-37. PubMed ID: 20977405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
